Immunologic effects of nonsteroidal anti-inflammatory agents

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

The information reviewed allows us to reassess our previously held assumption that NSAIAs work by removing 'proinflammatory' prostaglandins. However, it does not allow us to deduce the real mechanism of action of these drugs. Perhaps NSAIAs work in part by inhibiting rheumatoid factor production by 'depressing' suppressor cell function in the synovium. Perhpas they work by inhibiting the release of collagenase from monocytes or by inhibiting neutrophil migration and activation. Perhpas all of these mechanisms are involved. Perversely, many of the immunologic effects of NSAIAs may very well be detrimental to patients with rheumatoid arthritis, particularly as regards the stimulation of cytotoxicity. However, it should be clear to any clinician, that NSAIAs, whatever their mechanism or mechanisms of action, are therapeutically less than optimal in the patient with rheumatoid arthritis. If they are more than palliative, it is not overwhelmingly obvious. The importance of determining the mechanism of action of NSAIAs is clear, for we cannot intelligently and efficiently design more efficacious or less toxic drugs without an understanding of the mechanisms of efficacy and toxicity of drugs currently in use. Without such knowledge, the search for better agents is reduced to serendipity.

Original languageEnglish (US)
Pages (from-to)793-804
Number of pages12
JournalMedical Clinics of North America
Volume69
Issue number4
StatePublished - 1985
Externally publishedYes

Fingerprint

Non-Steroidal Anti-Inflammatory Agents
Rheumatoid Arthritis
Neutrophil Activation
Synovial Membrane
Rheumatoid Factor
Poisons
Collagenases
Drug-Related Side Effects and Adverse Reactions
Pharmaceutical Preparations
Prostaglandins
Monocytes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Immunologic effects of nonsteroidal anti-inflammatory agents. / Goodwin, James.

In: Medical Clinics of North America, Vol. 69, No. 4, 1985, p. 793-804.

Research output: Contribution to journalArticle

@article{f5c99ee7c4f8497299ad7c68f3852b5e,
title = "Immunologic effects of nonsteroidal anti-inflammatory agents",
abstract = "The information reviewed allows us to reassess our previously held assumption that NSAIAs work by removing 'proinflammatory' prostaglandins. However, it does not allow us to deduce the real mechanism of action of these drugs. Perhaps NSAIAs work in part by inhibiting rheumatoid factor production by 'depressing' suppressor cell function in the synovium. Perhpas they work by inhibiting the release of collagenase from monocytes or by inhibiting neutrophil migration and activation. Perhpas all of these mechanisms are involved. Perversely, many of the immunologic effects of NSAIAs may very well be detrimental to patients with rheumatoid arthritis, particularly as regards the stimulation of cytotoxicity. However, it should be clear to any clinician, that NSAIAs, whatever their mechanism or mechanisms of action, are therapeutically less than optimal in the patient with rheumatoid arthritis. If they are more than palliative, it is not overwhelmingly obvious. The importance of determining the mechanism of action of NSAIAs is clear, for we cannot intelligently and efficiently design more efficacious or less toxic drugs without an understanding of the mechanisms of efficacy and toxicity of drugs currently in use. Without such knowledge, the search for better agents is reduced to serendipity.",
author = "James Goodwin",
year = "1985",
language = "English (US)",
volume = "69",
pages = "793--804",
journal = "Medical Clinics of North America",
issn = "0025-7125",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Immunologic effects of nonsteroidal anti-inflammatory agents

AU - Goodwin, James

PY - 1985

Y1 - 1985

N2 - The information reviewed allows us to reassess our previously held assumption that NSAIAs work by removing 'proinflammatory' prostaglandins. However, it does not allow us to deduce the real mechanism of action of these drugs. Perhaps NSAIAs work in part by inhibiting rheumatoid factor production by 'depressing' suppressor cell function in the synovium. Perhpas they work by inhibiting the release of collagenase from monocytes or by inhibiting neutrophil migration and activation. Perhpas all of these mechanisms are involved. Perversely, many of the immunologic effects of NSAIAs may very well be detrimental to patients with rheumatoid arthritis, particularly as regards the stimulation of cytotoxicity. However, it should be clear to any clinician, that NSAIAs, whatever their mechanism or mechanisms of action, are therapeutically less than optimal in the patient with rheumatoid arthritis. If they are more than palliative, it is not overwhelmingly obvious. The importance of determining the mechanism of action of NSAIAs is clear, for we cannot intelligently and efficiently design more efficacious or less toxic drugs without an understanding of the mechanisms of efficacy and toxicity of drugs currently in use. Without such knowledge, the search for better agents is reduced to serendipity.

AB - The information reviewed allows us to reassess our previously held assumption that NSAIAs work by removing 'proinflammatory' prostaglandins. However, it does not allow us to deduce the real mechanism of action of these drugs. Perhaps NSAIAs work in part by inhibiting rheumatoid factor production by 'depressing' suppressor cell function in the synovium. Perhpas they work by inhibiting the release of collagenase from monocytes or by inhibiting neutrophil migration and activation. Perhpas all of these mechanisms are involved. Perversely, many of the immunologic effects of NSAIAs may very well be detrimental to patients with rheumatoid arthritis, particularly as regards the stimulation of cytotoxicity. However, it should be clear to any clinician, that NSAIAs, whatever their mechanism or mechanisms of action, are therapeutically less than optimal in the patient with rheumatoid arthritis. If they are more than palliative, it is not overwhelmingly obvious. The importance of determining the mechanism of action of NSAIAs is clear, for we cannot intelligently and efficiently design more efficacious or less toxic drugs without an understanding of the mechanisms of efficacy and toxicity of drugs currently in use. Without such knowledge, the search for better agents is reduced to serendipity.

UR - http://www.scopus.com/inward/record.url?scp=0022393598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022393598&partnerID=8YFLogxK

M3 - Article

C2 - 2932612

AN - SCOPUS:0022393598

VL - 69

SP - 793

EP - 804

JO - Medical Clinics of North America

JF - Medical Clinics of North America

SN - 0025-7125

IS - 4

ER -